Dose-range Finding Treosulfan-based Conditioning
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hematological Malignancies
Related studies linked through entity extraction aliases.
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
- Status
- COMPLETED
- Phase
- N/A
Extracorporal Photopheresis Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
- Status
- COMPLETED
- Phase
- NA
Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Exercise During Chemotherapy for Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- PHASE3
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
- Status
- COMPLETED
- Phase
- N/A
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Intrabone Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE4
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Trial Of Double Umbilical Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings
- Status
- COMPLETED
- Phase
- PHASE2
Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
- Status
- COMPLETED
- Phase
- PHASE4